242
Views
7
CrossRef citations to date
0
Altmetric
Review

Comparison of mechanical cardiopulmonary support strategies during lung transplantation

, , , , &
Pages 1075-1093 | Received 19 Jun 2020, Accepted 21 Oct 2020, Published online: 21 Nov 2020

References

  • Chambers DC, Yusen RD, Cherikh WS, et al. The registry of the international society for heart and lung transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36(10):1047–1059.
  • Trulock EP, Edwards LB, Taylor DO, et al. Registry of the international society for heart and lung transplantation: twenty-second official adult lung and heart-lung transplant report–2005. J Heart Lung Transplant. 2005;24(8):956–967.
  • Christie JD, Carby M, Bag R, et al. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the international society for heart and lung transplantation. J Heart Lung Transplant. 2005;24(10):1454–1459.
  • DerHovanessian A, Wallace WD, Lynch JP, et al. Chronic lung allograft dysfunction: evolving concepts and therapies. Semin Respir Crit Care Med. 2018;39(2):155‐171.
  • González FJ, Alvarez A, Cantador B, et al. Relationship among radiological measurements of anterior mediastinal fat and outcomes of lung transplantation in fibrotic patients. Arch Bronconeumol. 2020 Jan 22;1–8. 10.1016/j.arbres.2019.12.002.
  • Waseda R, Benazzo A, Hoetzenecker K, et al. The influence of retransplantation on survival for pediatric lung transplant recipients. J Thorac Cardiovasc Surg. 2018;156(5):2025–2034.
  • Cottini SR, Brandi G, Pagnamenta A, et al. Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation. Clin Transplant. 2018;32(5):e13251.
  • Shah PR, Boisen ML, Winger DG, et al. Extracorporeal support during bilateral sequential lung transplantation in patients with pulmonary hypertension: risk factors and outcomes. J Cardiothorac Vasc Anesth. 2017;31(2):418–425.
  • Raghavan D, Gao A, Ahn C, et al. Contemporary analysis of incidence of post-operative atrial fibrillation, its predictors, and association with clinical outcomes in lung transplantation. J Heart Lung Transplant. 2015;34(4):563–570.
  • Evans CF, Iacono AT, Sanchez PG, et al. Venous thromboembolic complications of lung transplantation: a contemporary single-institution review. Ann Thorac Surg. 2015;100(6):2033–2039.
  • Bittner HB, Lehmann S, Rastan A, et al. Outcome of extracorporeal membrane oxygenation as a bridge to lung transplantation and graft recovery. Ann Thorac Surg. 2012;94(3):942–949.
  • Algar FJ, Espinosa D, Moreno P, et al. Results of lung transplantation in idiopathic pulmonary fibrosis patients. Transplant Prog. 2010;42(8):3211–3213.
  • Atkins BZ, Petersen RP, Daneshmand MA, et al. Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation. Ann Thorac Surg. 2010;90(5):1662–1668.
  • Vigneswaran WT, Helenowski M, Bhorade SM, et al. Early readmission is a predictor of overall survival following isolated lung transplantation. Int Surg. 2010;95(4):299–304.
  • Paradela M, Gonzalez D, Parente I, et al. Surgical risk factors associated with lung transplantation. Transplant Proc. 2009;41(6):2218–2220.
  • SD F, DL M, Pelaez A, et al. Outcomes of delayed chest closure after bilateral lung transplantation. Ann Thorac Surg. 2006;81(6):2020–2024. .
  • Bittner HB, Richter M, Kuntze T, et al. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation. Eur J Cardiothorac Surg. 2006;29(2):210–215.
  • Kiziltug H, Falter F. Circulatory support during lung transplantation. Curr Opin Anaestehsiol. 2020;33(1):37–42.
  • O’Neil MP, Alie R, Guo LR, et al. Microvascular responsiveness to pulsatile and nonpulsatile flow during cardiopulmonary bypass. Ann Thorac Surg. 2018;105(6):1745‐1753.
  • Hoetzenecker K, Schwarz S, Muckenhuber M, et al. Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation. J Thorac Cardiovasc Surg. 2018;155(5):2193–2206.
  • Hlozek CC, Smedira NG, Kirby TJ, et al. Cardiopulmonary bypass (CPB) for lung transplantation. Perfusion. 1997;12(2):107–112.
  • Hashimoto K, Hoetzenecker K, Yeung JC, et al., Intraoperative extracorporeal support during lung transplantation in patients bridged with venovenous extracorporeal membrane oxygenation. J Heart Lung Transplant. 37(12): 1418–1424. 2018.
  • Yu WS, Paik HC, Haam SJ, et al. Transition to routine use of venoarterial extracorporeal oxygenation during lung transplantation could improve early outcomes. J Thorac Dis. 2016;8(7):1712–1720.
  • Salman J, Ius F, Sommer W, et al. Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension. Eur J Cardiothorac Surg. 2017;52(1):163–170.
  • Ius F, Sommer W, Tudorache I, et al., Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: indications and midterm results. J Heart Lung Transplant. 35(1): 49–58. 2016.
  • Taka H, Miyoshi K, Kurosaki T, et al. Lung transplantation via cardiopulmonary bypass: excellent survival outcomes from extended criteria donors. Gen Thorac Cardiovasc Surg. 2019;67(7):624–632.
  • Sarkar M, Prabhu V. Basics of cardiopulmonary bypass. Indian J Anaesth. 2017;61(9):760–767.
  • Aljure OD, Fabbro M. Cardiopulmonary bypass and inflammation: the hidden enemy. J Cardiothorac Vasc Anesth. 2019;33(2):346–347.
  • Bronicki RA, Hall M. Cardiopulmonary bypass-induced inflammatory response: pathophysiology and treatment. Pediatric Critical Care Med. 2016;17(8):S272–S278.
  • Boodram S, Evans E. Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass: a review. J Extra Corpor Technol. 2008;40(1):27–42.
  • Yavari M, Becker RC. Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass. J Thromb Thrombolysis. 2009;27(1):95–104.
  • Scrascia G, Rotunno C, Guida P, et al. Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system. Interact Cardiovasc Thorac Surg. 2013;16(5):636–642.
  • Dyke CM, Smedira NG, Koster A, et al. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg. 2006;131(3):533–539.
  • Welsh KJ, Nedelcu E, Bai Y, et al. How do we manage cardiopulmonary bypass coagulopathy? Transfusion. 2014;54(9):2158–2166.
  • Bermudez CA, Shiose A, Esper SA, et al., Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation. Ann Thorac Surg. 98(6): 1936–1943. 2014.
  • Shore-Lesserson L, Baker RA, Ferraris V, et al. STS/SCA/AmSECT clinical practice guidelines: anticoagulation during cardiopulmonary bypass. J Extra Corpor Technol. 2018;50(1):5.
  • Madhavan S, Chan SP, Tan WC, et al. Cardiopulmonary bypass time: every minute counts. J Cardiovasc Surg (Torino). 2018;59(2):274‐281.
  • Machuca TN, Collaud S, Mercier O, et al., Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg. 149(4): 1152–1157. 2015.
  • Hoechter DJ, von Dossow V, Winter H, et al., The munich lung transplant group: intraoperative extracorporeal circulation in lung transplantation. Thorac Cardiovasc Surg. 63(8): 706–714. 2015.
  • Al-Fares A, Pettenuzzo T, Del Sorbo L. Extracorporeal life support and systemic inflammation. Intensive Care Med Exp. 2019;7(1):46.
  • McRae K, de Perrot M. Principles and indications of extracorporeal life support in general thoracic surgery. J Thorac Dis. 2018;10(S8):S931–S946.
  • Bharat A, DeCamp MM. Veno-arterial extracorporeal membrane oxygenation without therapeutic anticoagulation for intra-operative cardiopulmonary support during lung transplantation. J Thorac Dis. 2017;9(7):E629.
  • Jayaraman AL, Cormican D, Shah P, et al. Cannulation strategies in adult veno-arterial and veno-venous extracorporeal membrane oxygenation: techniques, limitations, and special considerations. Ann Card Anaesth. 2017;20(5):S11–S18.
  • Gulack BC, Hirji SA, Hartwig MG, et al. Bridge to lung transplantation and rescue post-transplant: the expanding role of extracorporeal membrane oxygenation. J Thorac Dis. 2014;6(8):1070–1079.
  • Glorion M, Mercier O, Mitilian D, et al. Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension. Eur J Cardiothorac Surg. 2018;54(2):341–347.
  • Bonicolini E, Martucci G, Simons J, et al. Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: a narrative review of incidence, prevention, monitoring, and treatment. Crit Care. 2019 Dec 1;23(1):266.
  • Choi JH, Kim SW, Kim YU, et al. Application of veno-arterial-venous extracorporeal membrane oxygenation in differential hypoxia. Multidiscip Respir Med. 2014;9(1):1–5.
  • Shafii AE, McCurry KR. Subclavian insertion of the bicaval dual lumen cannula for venovenous extracorporeal membrane oxygenation. Ann Thorac Surg. 2012;94(2):663–665.
  • Gray A, Mulvihill MS, Hartwig MG, et al. Lung transplantation at Duke. J Thorac Dis. 2016;8(3):E185–196.
  • Tipograf Y, Gannon WD, Foley NM, et al. A dual-lumen bicaval cannula for venovenous extracorporeal membrane oxygenation. Ann Thorac Surg. 2020;109(4):1047–1053.
  • Cernak V, Oude Lansink-Hartgring A, van den Heuvel ER, et al. Incidence of massive transfusion and overall transfusion requirements during lung transplantation over a 25-year period. J Cardiothorac Vasc Anesth. 2019;33(9):2478‐2486.
  • Szeto WY, Kreisel D, Karakousis GC, et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg. 2002;124(2):241–249.
  • de Boer WJ, Hepkema BG, Loef BG, et al. Survival benefit of cardiopulmonary bypass support in bilateral lung transplantation for emphysema patients. Transplantation. 2002;73(10):1621–1627.
  • Dalibon N, Geffroy A, Moutafis M, et al., Use of cardiopulmonary bypass for lung transplantation: a 10-year experience. J Cardiothorac Vasc Anesth. 20(5): 668–672. 2006.
  • Wang Y, Kurichi JE, Blumenthal NP, et al. Multiple variables affecting blood usage in lung transplantation. J Heart Lung Transplant. 2006;25(5):533–538.
  • Burdett C, Butt T, Lordan J, et al. Comparison of single lung transplant with and without the use of cardiopulmonary bypass. Interact Cardiovasc Thorac Surg. 2012;15(3):432–436.
  • Pochettino A, Augoustides JG, Kowalchuk DA, et al. Cardiopulmonary bypass for lung transplantation in cystic fibrosis: pilot evaluation of perioperative outcome. J Cardiothorac Vasc Anesth. 2007;21(2):208–211.
  • Scaravilli V, Morlacchi LC, Merrino A, et al. Intraoperative extracorporeal membrane oxygenation for lung transplantation in cystic fibrosis. J Cyst Fibros. 2020;19(4):659–665.
  • Snell GI, Yusen RD, Weill D, et al. Report of the ISHLT working group on primary lung graft dysfunction, part i: definition and grading-a 2016 consensus group statement of the international society for heart and lung transplantation. J Heart Lung Transplant. 2017;36(10):1097–1103.
  • Prekker ME, Nath DS, Walker AR, et al. Validation of the proposed international society for heart and lung transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2006;25(4):371–378.
  • Kawut SM, Okun J, Shimbo D, et al. Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. Chest. 2009;136(1):237–244.
  • Allen JG, Lee MT, Weiss ES, et al. Preoperative recipient cytokine levels are associated with early lung allograft dysfunction. Ann Thorac Surg. 2012;93(6):1843–1849. .
  • Diamond JM, Lee JC, Kawut SM, et al., Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 187(5): 527–534. 2013.
  • Raphael J, Collins SR, Wang XQ, et al. Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2017;36(9):948–956.
  • Porteous MK, Lee JC, Lederer DJ, et al. Clinical risk factors and prognostic model for primary graft dysfunction after lung transplantation in patients with pulmonary hypertension. Ann Am Thorac Soc. 2017;14(10):1514–1522.
  • Guillen RV, Briones FR, Marin PM, et al. Lung graft dysfunction in the early postoperative period after lung and heart lung transplantation. Transplant Proc. 2005;37(9):3994–3995. .
  • Mohite PN, Sabashnikov A, Patil NP, et al., The role of cardiopulmonary bypass in lung transplantation. Clin Transplant. 30(2): 202–209. 2016.
  • Ceriana P, Klersy C, Veronesi R, et al. Influence of underlying lung disease on early postoperative course after single lung transplantation. J Cardiovasc Surg. 2002;43(5):715–722.
  • Padia SA, Borja MC, Orens JB, et al. Tracheostomy following lung transplantation predictors and outcomes. AM J Transplant. 2003;3(7):891–895.
  • Nguyen AP, Gabriel RA, Golts E, et al. Severity of acute kidney injury in the post-lung transplant patient is associated with higher healthcare resources and cost. J Cardiothorac Vasc Anesth. 2017;31(4):1361–1369.
  • Hennessy SA, Giller JR, Hranjec T, et al. Influence of hemodialysis on clinical outcomes after lung transplantation. J Surg Res. 2013;183(2):916–921.
  • Boldt J, Brenner T, Lehmann A, et al. Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg. 2003;75(3):906–912.
  • Fischer UM, Weissenberger WK, Warters RD, et al. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion. 2002;17(6):401–406. .
  • Martinu T, Pavlisko EN, Chen D, et al. Acute allograft rejection: cellular and humoral processes. Clin Chest Med. 2011;32(2):295–310.
  • Royer PJ, Olivera-Botello G, Koutsokera A, et al. Chronic lung allograft dysfunction: a systematic review of mechanisms. Transplantation. 2016;100(9):1803‐1814.
  • Verleden SE, Vos R, Vanaudenaerde BM, et al. Chronic lung allograft dysfunction phenotypes and treatment. J Thorac Dis. 2017;9(8):2650‐2659.
  • Moffatt-Bruce SD, Karamichalis J, Robbins RC, et al. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Ann Thorac Surg. 2006;81(1):286–291.
  • Ferrer J, Rodriguez E, Roman A, et al. Factors related to postoperative mortality in lung transplantation for emphysema. Transplant Proc. 2007;39(10):3317–3322.
  • Sekine Y, Waddell TK, Matte-Martyn A, et al. Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant. 2004;23(1):96–104.
  • Sabashnikov A, Weymann A, Mohite PN, et al. Risk factors predictive of one-year mortality after lung transplantation. Eur J Cardiothorac Surg. 2014;46(6):e82–88.
  • Cassivi SD, Meyers BF, Battafarano RJ, et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg. 2002;74(5):1663–1669.
  • Machuca TN, Schio SM, Camargo SM, et al. Prognostic factors in lung transplantation: the santa casa de porto alegre experience. Transplantation. 2011;91(11):1297–1303.
  • Bates M, Factor M, Parrino PE, et al. Lung transplantation and the routine use of cardiopulmonary bypass and median sternotomy: experience at the ochsner multi-organ transplant institute. Oschsner J. 2017;17(1):38–41.
  • Gunes A, Aboyoun CL, Morton JM, et al. Lung transplantation for chronic obstructive pulmonary disease at St Vincent’s Hospital. Intern Med J. 2006;36(1):5–11.
  • Ayyat KS, Elgharably H, Okamoto T, et al. Lung transplantation on cardiopulmonary bypass: time matters. J Heart Lung Transplant. 2020 Apr 1;39(4):S327.
  • Ius F, Kuehn C, Tudorache I, et al., Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg. 144(6): 1510–1516. 2012.
  • Dell’Amore A, Campisi A, Congiu, et al. Extracorporeal life support during and after bilateral sequential lung transplantation in patients with pulmonary artery hypertension. Artif Organs. 2020 Jun;44(6):628–637.
  • Biscotti M, Yang J, Sonett J, et al. Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg. 2014;148(5):2410–2415.
  • Bittner HB, Binner C, Lehmann S, et al. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg. 2007;31(3):462–467.
  • Pettenuzzo T, Faggi G, Di Gregorio G, et al. Blood Products transfusion and mid-term outcomes of lung transplanted patients under extracorporeal membrane oxygenation support. Prog Transplant. 2018;28(4):314–321.
  • Ko WJ, Chen YS, Lee YC. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Artif Organs. 2001;25(8):607–612.
  • Nosotti M, Palleschi A, Rosso L, et al. Clinical risk factors for primary graft dysfunction in a low-volume lung transplantation center. Transplant Proc. 2014;46(7):2329–2333.
  • Hoetzenecker K, Benazzo A, Stork T, et al. Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: an observational study. J Thorac Cardiovasc Surg. 2020;160(1):320–327.
  • Ortiz P, Kashem M, Sunagawa G, et al. Comparing the use of extracorporeal membrane oxygenation and cardiopulmonary bypass in lung transplantation. J Heart Lung Transplant. 2020;39(4):S104.
  • Narm KS, Lee S, Suh JW, et al. Risk factor analysis for intraoperative extracorporeal membrane oxygenation weaning failure after lung transplantation. Ann Thorac Surg. 2018;105(1):242–248.
  • Fessler J, Sage E, Roux A, et al. Is extracorporeal membrane oxygenation withdrawal a safe option after double-lung transplantation? Ann Thorac Surg. 2020;110(4):1167–1174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.